21 results  1 of 2 

1 Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens
Hae-Young Park, Jin-Won Kwon, Hye-Lin Kim, Sun-Hong Kwon, Jin Hyun Nam, Serim Min, In-Sun Oh, Sungho Bea, Sun Ha Choi
J Korean Med Sci.2023;38(21):e167.  Published online 2023 May 2     DOI: http://dx.doi.org/10.3346/jkms.2023.38.e167
      
2 Mycobacterial infections in solid organ transplant recipients
Harun Ur Rashid, Nura Afza Salma Begum, Tasnuva Sarah Kashem
Korean J Transplant.2021;35(4):208-217.   Published online 2021 December 31     DOI: http://dx.doi.org/10.4285/kjt.21.0033
      
3 Differentiating between Intestinal Tuberculosis and Crohn’s Disease May Be Complicated by Multidrug-resistant Mycobacterium tuberculosis
Seung Wook Hong, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang
Ewha Med J.2021;44(3):93-96.   Published online 2021 July 31     DOI: http://dx.doi.org/10.12771/emj.2021.44.3.93
      
4 Diagnosis and treatment of multidrug-resistant tuberculosis
Jong Geol Jang, Jin Hong Chung
Yeungnam Univ J Med.2020;37(4):277-285.   Published online 2020 September 4     DOI: http://dx.doi.org/10.12701/yujm.2020.00626
      
5 Impact of Molecular Drug Susceptibility Testing on the Time to Multidrug-resistant Tuberculosis Treatment Initiation
Doosoo Jeon, Hyungseok Kang, Yong-Soo Kwon, Jae-Joon Yim, Tae Sun Shim
J Korean Med Sci.2020;35(35):e284.  Published online 2020 August 3     DOI: http://dx.doi.org/10.3346/jkms.2020.35.e284
      
6 Evaluation of the QuantaMatrix Multiplexed Assay Platform for Molecular Diagnosis of Multidrug- and Extensively Drug-Resistant Tuberculosis Using Clinical Strains Isolated in Myanmar
Yunhee Chang, Seoyong Kim, Yeun Kim, Phyu Win Ei, Dasom Hwang, Jongseok Lee, Chulhun L Chang, Hyeyoung Lee
Ann Lab Med.2020;40(2):142-147.   Published online 2019 October 23     DOI: http://dx.doi.org/10.3343/alm.2020.40.2.142
      
7 Drug Resistance Patterns of Multidrug- and Extensively Drug-Resistant Tuberculosis in Korea: Amplification of Resistance to Oral Second-line Drugs
Chang-Ki Kim, So Youn Shin, Hee Jin Kim, Kyungwon Lee
Ann Lab Med.2017;37(4):323-326.   Published online 2017 April 19     DOI: http://dx.doi.org/10.3343/alm.2017.37.4.323
   
8 Risk Factors for Poor Outcomes in Patients with Multi-Drug Resistant Tuberculosis in South Korea
Jun Ho Yang, Hyun Oh Park, Joung Hun Byun, Sung Hwan Kim, Sung Ho Moon, Jong Duk Kim, Dea Yeon Kim
Hanyang Med Rev.2016;36(4):262-268.   Published online 2016 November 24     DOI: http://dx.doi.org/10.7599/hmr.2016.36.4.262
      
9 Clinical Features and Management of Multidrug-Resistant Tuberculosis
Jae Cheol Lee, Chul Gyu Yoo, Hee Soon Cheong, Young Whan Kim, Sung Koo Han, Young Soo Shim
Tuberc Respir Dis.1996;43(1):14-21.   Published online 2016 March 15     DOI: http://dx.doi.org/10.4046/trd.1996.43.1.14
      
10 Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis
Eun Soo Kwon, Hyun Cheol Ha, Su Hee Hwang, Hung Yol Lee, Seung Kyu Park, Sun Dae Song
Tuberc Respir Dis.1998;45(6):1143-1153.   Published online 2016 March 14     DOI: http://dx.doi.org/10.4046/trd.1998.45.6.1143
      
11 The Analysis of Risk Factors of Treatment Failure in MDR-TB
Hyoung Soo Kim, Kwang Min Choi
Tuberc Respir Dis.2001;50(6):686-692.   Published online 2016 March 9     DOI: http://dx.doi.org/10.4046/trd.2001.50.6.686
      
12 The Clinical Characteristics of Initial Drug Resistance in MDR-TB Patients
Hyoung Soo Kim, Kwang Suk Rho, Suck Jun Kong, Mal Hyeun Sohn, Tae Yoon Kim
Tuberc Respir Dis.2001;51(5):409-415.   Published online 2016 March 9     DOI: http://dx.doi.org/10.4046/trd.2001.51.5.409
      
13 Issues Related to the Updated 2014 Korean Guidelines for Tuberculosis
Jae Seuk Park
Tuberc Respir Dis.2016;79(1):1-4.   Published online 2015 December 31     DOI: http://dx.doi.org/10.4046/trd.2016.79.1.1
      
14 Performance Evaluation of Anyplex Plus MTB/NTM and MDR-TB Detection Kit for Detection of Mycobacteria and for Anti-Tuberculosis Drug Susceptibility Test
Jun Hyung Lee, Bo Hyun Kim, Mi-Kyung Lee
Ann Clin Microbiol.2014;17(4):115-122.   Published online 2014 December 5     DOI: http://dx.doi.org/10.5145/ACM.2014.17.4.115
   
15 Molecular Detection of Fluoroquinolone Resistance in Multidrug-Resistant Mycobacterium tuberculosis Isolates
Chang-Ki Kim, Byung Soo Lee, Myung Joon Choi, Hee Jin Kim, Kyungwon Lee
Ann Clin Microbiol.2014;17(3):80-85.   Published online 2014 September 5     DOI: http://dx.doi.org/10.5145/ACM.2014.17.3.80
   
16 Diagnosis and treatment of multidrug-resistant tuberculosis
Young Ae Kang
J Korean Med Assoc.2014;57(1):27-33.   Published online 2014 January 16     DOI: http://dx.doi.org/10.5124/jkma.2014.57.1.27
      
17 Proportion of Multidrug-Resistant Tuberculosis in Human Immunodeficiency Virus/Mycobacterium tuberculosis Co-Infected Patients in Korea
Joon Sung Joh, H. Christian Hong, In A Jeong, Bum Sik Chin, Hye Jin Yang, Hongjo Choi, Ji Hwan Bang
J Korean Med Sci.2012;27(10):1143-1146.   Published online 2012 October 2     DOI: http://dx.doi.org/10.3346/jkms.2012.27.10.1143
      
18 Multidrug-resistant Tuberculosis
Jae-Joon Yim
J Korean Med Assoc.2006;49(9):790-798.   Published online 2006 September 30     DOI: http://dx.doi.org/10.5124/jkma.2006.49.9.790
      
19 The Current Status of Multidrug-resistant Tuberculosis in Korea
Byoung-Ju Kim, In-Hee Lee, Duk-Hyung Lee, Gill-Han Bai, Suk-Jun Kong, Sun-Hwa Lee, Hae-Ran Moon, Kyoung-Ryul Lee, Jun-Young Lee, Seung-Kyu Park
Tuberc Respir Dis.2006;60(4):404-411.   Published online 2006 April 30     DOI: http://dx.doi.org/10.4046/trd.2006.60.4.404
      
20 A Retrospective Study for Relapse Rate According to the Discontinuance of Para-aminosalicylic acid(PAS) after Bacteriological Conversion during the Course of Chemotherapy for Multidrug- Resistant Tuberculosis(MDR-TB)
Seung-Kyu Park, Byoung-Ju Kim, Dong-Ohk Shin, Byung-Yool Jun
Tuberc Respir Dis.2006;60(2):180-186.   Published online 2006 February 28     DOI: http://dx.doi.org/10.4046/trd.2006.60.2.180
      

 1 of 2